Cited by 196Protein purification and stabilityBiosimilars and Bioanalytical MethodsAnalytical Methods in Pharmaceuticals

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

A Critical Review of Methods for Size Characterization of Non-Particulate Protein Aggregates

Philo, John·2009·Current Pharmaceutical Biotechnology

DOI 10.2174/138920109788488815

Open this paper in CoChat — free account

Abstract

Although size exclusion chromatography (SEC) has been, and will continue to be, the primary analytical tool for characterization of the content and size distribution of non-particulate aggregates in protein pharmaceuticals, regulatory concerns are driving increased use of alternative and complementary methods such as analytical ultracentrifugation and light scattering techniques. This review will highlight and critically review the capabilities, advantages, and drawbacks of SEC, analytical ultracentrifugation, and light scattering methods for characterizing aggregates with sizes below about 0.3 microns. The physical principles of the biophysical methods are briefly described and examples of data for real samples and how that data is interpreted are given to help clarify capabilities and weaknesses.

Integrity signals

Registry

Crossref · 10.2174/138920109788488815

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Techniques in Protein Chemistry
(1993) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(93)80012-n · Cited by 1,298

Show all 1 references

Sorted by citations

Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885
Protein aggregation—Pathways and influencing factors
Wang, W., Nema, S., & Teagarden, D. L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.025 · Cited by 842
Characterization of Therapeutic Antibodies and Related Products
Beck, A., Wagner‐Rousset, E., Ayoub, D., DORSSELAER, A. V., & Cianférani, S. (2012) · Analytical Chemistry · doi:10.1021/ac3032355 · Cited by 616
Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars
Berkowitz, S. A., Engen, J. R., Mazzeo, J. R., & Jones, G. B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3746 · Cited by 550
Immunogenicity of Therapeutic Protein Aggregates
Moussa, E. M., Panchal, J. P., Moorthy, B. S., Blum, J. S., Joubert, M. K., Narhi, L. O., & Topp, E. M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.002 · Cited by 525
Strategies for the assessment of protein aggregates in pharmaceutical biotech product development
den Engelsman, J., Garidel, P., Smulders, R., Koll, H., Smith, B., Bassarab, S., Seidl, A., Hainzl, O., & Jiskoot, W. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0297-1 · Cited by 348
An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein Therapeutics
Singh, S. K., Afonina, N., Awwad, M., Bechtold-Peters, K., Blue, J. T., Chou, D. K., Cromwell, M. E. M., Krause, H.-J., Mahler, H., Meyer, B. K., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22097 · Cited by 337
Protein aggregation – Mechanisms, detection, and control
Wang, W., & Roberts, C. J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.043 · Cited by 328
Protein aggregation, particle formation, characterization & rheology
Amin, S., Barnett, G. V., Pathak, J. A., Roberts, C. J., & Sarangapani, P. S. (2014) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2014.10.002 · Cited by 283
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B. D., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2018) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 283
Protein Instability and Immunogenicity: Roadblocks to Clinical Application of Injectable Protein Delivery Systems for Sustained Release
Jiskoot, W., Randolph, T. W., Volkin, D. B., Middaugh, C. R., Schöneich, C., Winter, G., Frieß, W., Crommelin, D. J. A., & Carpenter, J. F. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23018 · Cited by 251
Forced Degradation of Therapeutic Proteins
Hawe, A., Wiggenhorn, M., van de Weert, M., Garbe, J. H. O., Mahler, H., & Jiskoot, W. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22812 · Cited by 251
Particles in Therapeutic Protein Formulations, Part 1: Overview of Analytical Methods
Zölls, S., Tantipolphan, R., Wiggenhorn, M., Winter, G., Jiskoot, W., Frieß, W., & Hawe, A. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23001 · Cited by 232
Protein analysis by dynamic light scattering: Methods and techniques for students
Lorber, B., Fischer, F., Bailly, M. A., Roy, H., & Kern, D. (2012) · Biochemistry and Molecular Biology Education · doi:10.1002/bmb.20644 · Cited by 226
The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals
Arakawa, T., Ejima, D., Li, T., & Philo, J. S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21974 · Cited by 224
Self-citation
Taylor Dispersion Analysis Compared to Dynamic Light Scattering for the Size Analysis of Therapeutic Peptides and Proteins and Their Aggregates
Hawe, A., Hulse, W. L., Jiskoot, W., & Forbes, R. T. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0460-3 · Cited by 221
Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products
Carpenter, J. F., Randolph, T. W., Jiskoot, W., Crommelin, D. J. A., Middaugh, C. R., & Winter, G. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21989 · Cited by 202
Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes
Dwivedi, M., Blech, M., Presser, I., & Garidel, P. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.008 · Cited by 193
Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies
Gimpel, A. L., Katsikis, G., Sha, S., Maloney, A. J., Hong, M. S., Nguyen, T. N. T., Wolfrum, J., Springs, S. L., Sinskey, A. J., Manalis, S. R., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.010 · Cited by 185
Effects of Syringe Material and Silicone Oil Lubrication on the Stability of Pharmaceutical Proteins
Krayukhina, E., Tsumoto, K., Uchiyama, S., & Fukui, K. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24184 · Cited by 158
Therapeutic Fc‐fusion proteins: Current analytical strategies
Duivelshof, B. L., Murisier, A., Camperi, J., Fekete, S., Beck, A., Guillarme, D., & D’Atri, V. (2020) · Journal of Separation Science · doi:10.1002/jssc.202000765 · Cited by 153
Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies
Zhang, H., Cui, W., & Gross, M. L. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.027 · Cited by 158
Integrated Approach to Structure-Based Enzymatic Drug Design: Molecular Modeling, Spectroscopy, and Experimental Bioactivity
Honarparvar, B., Govender, T., Maguire, G. E. M., Soliman, M. E. S., & Kruger, H. G. (2013) · Chemical Reviews · doi:10.1021/cr300314q · Cited by 163
Circular Dichroism Spectroscopy as a Tool for Monitoring Aggregation in Monoclonal Antibody Therapeutics
Joshi, V. S., Shivach, T., Yadav, N., & Rathore, A. S. (2014) · Analytical Chemistry · doi:10.1021/ac503140j · Cited by 137
Characterization of Proteins by Size-Exclusion Chromatography Coupled to Multi-Angle Light Scattering (SEC-MALS)
Some, D., Amartely, H., Tsadok, A., & Lebendiker, M. (2019) · Journal of Visualized Experiments · doi:10.3791/59615 · Cited by 133
Challenges and opportunities in the advancement of nanomedicines
Wei, A., Mehtala, J. G., & Patri, A. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.007 · Cited by 117
Protein particles: What we know and what we do not know
Ripple, D. C., & Dimitrova, M. N. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23242 · Cited by 110
Concomitant Raman spectroscopy and dynamic light scattering for characterization of therapeutic proteins at high concentrations
Zhou, C., Qi, W., Lewis, E. N., & Carpenter, J. F. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.11.016 · Cited by 109
Analysis of Protein Aggregation in Neurodegenerative Disease
Pedersen, J. T., & Heegaard, N. H. H. (2013) · Analytical Chemistry · doi:10.1021/ac400023c · Cited by 113
Improving the solubility of anti‐LINGO‐1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis
Pepinsky, R. B., Silvian, L. F., Berkowitz, S. A., Farrington, G., Lugovskoy, A. A., Walus, L. R., Eldredge, J. K., Capili, A. D., Mi, S., Graff, C. P., et al. (2010) · Protein Science · doi:10.1002/pro.372 · Cited by 103
A Multilaboratory Comparison of Calibration Accuracy and the Performance of External References in Analytical Ultracentrifugation
Zhao, H., Ghirlando, R., Alfonso, C., Arisaka, F., Attali, I., Bain, D. L., Bakhtina, M., Becker, D., Bedwell, G. J., Bekdemir, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126420 · Cited by 99
Development of a Microflow Digital Imaging Assay to Characterize Protein Particulates During Storage of a High Concentration IgG1 Monoclonal Antibody Formulation
Wuchner, K., Büchler, J., Spycher, R., Dalmonte, P., & Volkin, D. B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22123 · Cited by 97
Characterization of Small Protein Aggregates and Oligomers Using Size Exclusion Chromatography with Online Detection by Native Electrospray Ionization Mass Spectrometry
Muneeruddin, K., Thomas, J. J., Salinas, P. A., & Kaltashov, I. A. (2014) · Analytical Chemistry · doi:10.1021/ac502590h · Cited by 96
Aggregated Recombinant Human Interferon Beta Induces Antibodies but No Memory in Immune-Tolerant Transgenic Mice
van Beers, M. M. C., Sauerborn, M., Gilli, F., Brinks, V., Schellekens, H., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0172-0 · Cited by 90
Advances on Size Exclusion Chromatography and Applications on the Analysis of Protein Biopharmaceuticals and Protein Aggregates: A Mini Review
Brusotti, G., Calleri, E., Colombo, R., Massolini, G., Rinaldi, F., & Temporini, C. (2017) · Chromatographia · doi:10.1007/s10337-017-3380-5 · Cited by 89
Triazolopyrimidines Are Microtubule-Stabilizing Agents that Bind the Vinca Inhibitor Site of Tubulin
Sáez-Calvo, G., Sharma, A., Balaguer, F. D. A., Barasoaı́n, I., Rodríguez‐Salarichs, J., Olieric, N., Muñoz-Hernández, H., Berbis, M. A., Wendeborn, S. V., Peñalva, M. A., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.05.016 · Cited by 84
Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)
Hong, J. H., Lee, Y., Lee, C., Eo, S., Kim, S.-Y., Lee, N., Park, J.-M., Park, S.-K., Seo, D., Jeong, M., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1264550 · Cited by 88
Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability
Singh, S. K., Luisi, D. L., & Pak, R. H. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1704-4 · Cited by 82
Physicochemical characterization of biopharmaceuticals
Parr, M. K., Montacir, O., & Montacir, H. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.05.028 · Cited by 84
Size exclusion chromatography of biopharmaceutical products: From current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles
D’Atri, V., Imiołek, M., Quinn, C. F., Finny, A. S., Lauber, M. A., Fekete, S., & Guillarme, D. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.464862 · Cited by 81
Analytical approaches to assess the degradation of therapeutic proteins
Filipe, V., Hawe, A., Carpenter, J. F., & Jiskoot, W. (2013) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2013.05.005 · Cited by 75
Accelerated Formulation Development of Monoclonal Antibodies (mAbs) and mAb-Based Modalities: Review of Methods and Tools
Razinkov, V. I., Treuheit, M. J., & Becker, G. W. (2015) · SLAS DISCOVERY · doi:10.1177/1087057114565593 · Cited by 77
A Novel Online Four-Dimensional SEC×SEC-IM×MS Methodology for Characterization of Monoclonal Antibody Size Variants
Ehkirch, A., Goyon, A., Hernandez‐Alba, O., Rouvière, F., D’Atri, V., Dreyfus, C., Haeuw, J., Diemer, H., Beck, A., Heinisch, S., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03333 · Cited by 73
Transmission Electron Microscopy as an Orthogonal Method to Characterize Protein Aggregates
Sung, J. J., Pardeshi, N. N., Mulder, A. M., Mulligan, S. K., Quispe, J. D., On, K., Carragher, B. O., Potter, C. S., Carpenter, J. F., & Schneemann, A. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24157 · Cited by 69
Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum
Filipe, V., Poole, R. A., Oladunjoye, O., Braeckmans, K., & Jiskoot, W. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0749-x · Cited by 68
Detection of IgG Aggregation by a High Throughput Method Based on Extrinsic Fluorescence
He, F., Phan, D. H. T., Hogan, S., Bailey, R. W., Becker, G. W., Narhi, L. O., & Razinkov, V. I. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22036 · Cited by 64
Evaluation of a Dual-Wavelength Size Exclusion HPLC Method With Improved Sensitivity to Detect Protein Aggregates and Its Use to Better Characterize Degradation Pathways of an IgG1 Monoclonal Antibody
Bond, M. D., Panek, M. E., Zhang, Z., Wang, D., Mehndiratta, P., Zhao, H., Gunton, K. E., Ni, A., Nedved, M. L., Burman, S., et al. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22034 · Cited by 64
Preparative Scale Cell-free Production and Quality Optimization of MraY Homologues in Different Expression Modes
Ma, Y., Münch, D., Schneider, T., Sahl, H., Bouhss, A., Ghoshdastider, U., Wang, J., Dötsch, V., Wang, X., & Bernhard, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301085 · Cited by 63
Analytical Platform for Monitoring Aggregation of Monoclonal Antibody Therapeutics
Bansal, R., Gupta, S., & Rathore, A. S. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2690-8 · Cited by 63
High-dose Monoclonal Antibodies Via the Subcutaneous Route: Challenges and Technical solutions, an Industry Perspective
Narasimhan, C. N., Mach, H., & Shameem, M. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.68 · Cited by 59
Selection of Analytical Technology and Development of Analytical Procedures Using the Analytical Target Profile
Borman, P. J., Campa, C., Delpierre, G., Hook, E. C., Jackson, P., Kelley, W. P., Protz, M., & Vandeputte, O. M. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03854 · Cited by 59
Physicochemical and functional characterization of vaccine antigens and adjuvants
Dey, A., Malyala, P., & Singh, M. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.907528 · Cited by 57
Oxidation of polysorbates – An underestimated degradation pathway?
Weber, J., Buske, J., Mäder, K., Garidel, P., & Diederichs, T. (2023) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2023.100202 · Cited by 59
What is the role of current mass spectrometry in pharmaceutical analysis?
Khalikova, M. A., Jireš, J., Horáček, O., Douša, M., Kučera, R., & Nováková, L. (2023) · Mass Spectrometry Reviews · doi:10.1002/mas.21858 · Cited by 53
Fluorescence Single Particle Tracking for the Characterization of Submicron Protein Aggregates in Biological Fluids and Complex Formulations
Filipe, V., Poole, R. A., Kutscher, M., Forier, K., Braeckmans, K., & Jiskoot, W. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0374-0 · Cited by 52
Measuring macromolecular size distributions and interactions at high concentrations by sedimentation velocity
Chaturvedi, S. K., Ma, J., Brown, P. H., Zhao, H., & Schuck, P. (2018) · Nature Communications · doi:10.1038/s41467-018-06902-x · Cited by 54
Biosimilarity Versus Manufacturing Change: Two Distinct Concepts
Declerck, P. J., Rezk, M. F., & Rudd, P. M. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1790-3 · Cited by 50
Does the Crowded Cell-like Environment Reduce the Chaperone-like Activity of α-Crystallin?
Roman, S. G., Chebotareva, N. A., Eronina, T. B., Kleymenov, S. Y., Makeeva, V. F., Poliansky, N. B., Muranov, K. O., & Kurganov, B. I. (2011) · Biochemistry · doi:10.1021/bi201030y · Cited by 48
Stem Cell-Derived Exosomes as Therapeutic Approach for Neurodegenerative Disorders: From Biology to Biotechnology
Araldi, R. P., D’Ámelio, F., Vigerelli, H., de Melo, T. C., & Kerkis, I. (2020) · Cells · doi:10.3390/cells9122663 · Cited by 49
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents
Brindisi, M., Ulivieri, C., Alfano, G., Gemma, S., Balaguer, F. D. A., Khan, T., Grillo, A., Chemi, G., Menchon, G., Prota, A. E., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.004 · Cited by 47
Multi‐Attribute PAT for UF/DF of Proteins—Monitoring Concentration, Particle Sizes, and Buffer Exchange
Rolinger, L., Rüdt, M., Diehm, J., Chow-Hubbertz, J., Heitmann, M., Schleper, S., & Hubbuch, J. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02318-8 · Cited by 46
Monitoring protein aggregation kinetics with simultaneous multiple sample light scattering
Drenski, M. F., Brader, M. L., Alston, R. W., & Reed, W. F. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.02.014 · Cited by 45
Evaluation of Electrospray Ionization Mass Spectrometry as a Tool for Characterization of Small Soluble Protein Aggregates
Wang, G., Johnson, A. J., & Kaltashov, I. A. (2011) · Analytical Chemistry · doi:10.1021/ac203017x · Cited by 42
Transient Molten Globules and Metastable Aggregates Induced by Brief Exposure of a Monoclonal IgG to Low pH
Filipe, V., Kaletaş, B. K., Hawe, A., & Jiskoot, W. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23157 · Cited by 41
Some Lessons Learned From a Comparison Between Sedimentation Velocity Analytical Ultracentrifugation and Size Exclusion Chromatography to Characterize and Quantify Protein Aggregates
Gandhi, A. V., Pothecary, M. R., Bain, D. L., & Carpenter, J. F. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.048 · Cited by 40
In Vivo Fluorescence Imaging of IgG1 Aggregates After Subcutaneous and Intravenous Injection in Mice
Filipe, V., Que, I., Carpenter, J. F., Löwik, C., & Jiskoot, W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1154-9 · Cited by 39
Comparison of particle size methodology and assessment of nanoparticle tracking analysis (NTA) as a tool for live monitoring of crystallisation pathways
McComiskey, K. P. M., & Tajber, L. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.07.012 · Cited by 39
Accelerated Stability Studies of Abatacept Formulations: Comparison of Freeze–Thawing- and Agitation-induced Stresses
Cordes, A. A., Carpenter, J. F., & Randolph, T. W. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23150 · Cited by 39
Morphological characterization of aggregates and agglomerates by image analysis: A systematic literature review
Théodon, L., Debayle, J., & Coufort‐Saudejaud, C. (2023) · Powder Technology · doi:10.1016/j.powtec.2023.119033 · Cited by 38
A simple and fast method to study the hydrodynamic size difference of protein disulfide isomerase in oxidized and reduced form using gold nanoparticles and dynamic light scattering
Zheng, T., Cherubin, P., Cilenti, L., Teter, K., & Huo, Q. (2015) · The Analyst · doi:10.1039/c5an02248g · Cited by 36
Sedimentation velocity analytical ultracentrifugation for characterization of therapeutic antibodies
Uchiyama, S., Noda, M., & Krayukhina, E. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0374-3 · Cited by 35
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2)
Luca, L., Capelle, M. A. H., Machaidze, G., Arvinte, T., Jordan, O., & Gurny, R. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.015 · Cited by 35
Characterization of Proteins by Size-Exclusion Chromatography Coupled to Multi-Angle Light Scattering (SEC-MALS)
Some, D., Amartely, H., Tsadok, A., & Lebendiker, M. (2019) · Journal of Visualized Experiments · doi:10.3791/59615-v · Cited by 34
Investigating the secondary interactions of packing materials for size-exclusion chromatography of therapeutic proteins
Fekete, S., Kizekai, L., Sarisozen, Y. T., Lawrence, N. L., Shiner, S. J., & Lauber, M. A. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463262 · Cited by 33
Particle Sizing Methods for The Detection of Protein Aggregates in Biopharmaceuticals
Khodabandehloo, A., & Chen, D. D. Y. (2017) · Bioanalysis · doi:10.4155/bio-2016-0269 · Cited by 32
Aggregation analysis of pharmaceutical human immunoglobulin preparations using size-exclusion chromatography and analytical ultracentrifugation sedimentation velocity
Krayukhina, E., Uchiyama, S., Nojima, K., Okada, Y., Hamaguchi, I., & Fukui, K. (2012) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2012.07.021 · Cited by 30
Water Proton NMR for In Situ Detection of Insulin Aggregates
Taraban, M. B., Truong, H. C., Feng, Y., Jouravleva, E. V., Anisimov, M. A., & Yu, Y. B. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24633 · Cited by 30
Best Practices for Aggregate Quantitation of Antibody Therapeutics by Sedimentation Velocity Analytical Ultracentrifugation
Bou-Assaf, G. M., Budyak, I. L., Brenowitz, M. D., Day, E. S., Hayes, D., Hill, J. J., Majumdar, R., Ringhieri, P., Schuck, P., & Lin, J. C. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.12.023 · Cited by 30
Characterization of a Protein Conjugate Using an Asymmetrical-Flow Field-Flow Fractionation and a Size-Exclusion Chromatography with Multi-Detection System
Rebolj, K., Pahovnik, D., & Žagar, E. (2012) · Analytical Chemistry · doi:10.1021/ac3010378 · Cited by 30
Impact of asymmetrical flow field-flow fractionation on protein aggregates stability
Bria, C. R. M., & Williams, S. K. R. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.08.037 · Cited by 28
Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments
Krayukhina, E., Noda, M., Ishii, K., Maruno, T., Wakabayashi, H., Tada, M., Suzuki, T., Ishii‐Watabe, A., Katô, M., & Uchiyama, S. (2017) · mAbs · doi:10.1080/19420862.2017.1297909 · Cited by 28
Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization
Schneider, K.-T., Kirmann, T., Wenzel, E. V., Grosch, J., Polten, S., Meier, D., Becker, M., Matejtschuk, P., Hust, M., Russo, G., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.717689 · Cited by 28
Characterization and Analysis of Biopharmaceutical Proteins
Luo, Y., Matejic, T., Ng, C.-K., Nunnally, B. K., Porter, T. J., Raso, S. W., Rouse, J. C., Shang, T. Q., & Steckert, J. (2010) · Separation science and technology · doi:10.1016/b978-0-12-375680-0.00008-5 · Cited by 26
Measuring Ultra-Weak Protein Self-Association by Non-ideal Sedimentation Velocity
Chaturvedi, S. K., Sagar, V., Zhao, H., Wistow, G. J., & Schuck, P. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11371 · Cited by 25
An automated interface for sedimentation velocity analysis in SEDFIT
Schuck, P., To, S. C., & Zhao, H. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011454 · Cited by 23
Mechanistic Complexity of Subvisible Particle Formation: Links to Protein Aggregation are Highly Specific
Simler, B. R., Hui, G., Dahl, J. E., & Pérez-Ramírez, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23299 · Cited by 23
The importance of being metal-free: The critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry
Murisier, A., Fekete, S., Guillarme, D., & D’Atri, V. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338987 · Cited by 27
On the use of size exclusion chromatography for the resolution of mixed amyloid aggregate distributions: I. Equilibrium partition models
Hall, D. R., & Huang, L. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.04.001 · Cited by 22
Protein Characterization in 3D: Size, Folding, and Functional Assessment in a Unified Approach
Pedersen, M. E., Gad, S. I., Østergaard, J., & Jensen, H. M. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00537 · Cited by 22
Thermally induced degradation pathways of three different antibody-based drug development candidates.
Fincke, A., Winter, J., Bunte, T., & Olbrich, C. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.014 · Cited by 24
Analytical Ultracentrifugation and Its Role in Development and Research of Therapeutical Proteins
Liu, J., Yadav, S., Andya, J. D., Demeule, B., & Shire, S. J. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.04.008 · Cited by 21
Different effects of l-arginine on the heat-induced unfolding and aggregation of proteins
Cirkovas, A., & Sereikaitė, J. (2011) · Biologicals · doi:10.1016/j.biologicals.2011.04.003 · Cited by 20
High Performance Size Exclusion Chromatography and High-Throughput Dynamic Light Scattering as Orthogonal Methods to Screen for Aggregation and Stability of Monoclonal Antibody Drug Products
Bhirde, A. A., Chikkaveeraiah, B. V., Venna, R., Carley, R., Brorson, K., & Agarabi, C. D. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.08.013 · Cited by 20
Analytical artifacts in characterization of recombinant monoclonal antibody therapeutics
Wang, D., Nowak, C., Mason, B. D., Katiyar, A., & Liu, H. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113131 · Cited by 19
Quantifying Trace Amounts of Aggregates in Biopharmaceuticals Using Analytical Ultracentrifugation Sedimentation Velocity: Bayesian Analyses and F Statistics
Wafer, L. N., Kloczewiak, M. A., & Luo, Y. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9925-y · Cited by 19
Analysis of Antibody Aggregate Content at Extremely High Concentrations Using Sedimentation Velocity with a Novel Interference Optics
Schilling, K., & Krause, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120820 · Cited by 17
Analysis of nonideality: insights from high concentration simulations of sedimentation velocity data
Correia, J. J., Wright, R. T., Sherwood, P. J., & Stafford, W. F. (2020) · European Biophysics Journal · doi:10.1007/s00249-020-01474-5 · Cited by 17
Quantitative measurement of aggregation kinetics process of nanoparticles using nanoparticle tracking analysis and dynamic light scattering
Wang, C., Lv, B., Hou, J., Wang, P., Miao, L., & Ci, H. (2019) · Journal of Nanoparticle Research · doi:10.1007/s11051-019-4527-0 · Cited by 17
Aqueous size‐exclusion chromatographic separations of intact proteins under native conditions: Effect of pressure on selectivity and efficiency
Vos, J. D., Kaal, E. R., Swart, R., Baca, M., Heyden, Y. V., & Eeltink, S. (2015) · Journal of Separation Science · doi:10.1002/jssc.201500895 · Cited by 16
Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis
Gruia, F., Parupudi, A., & Polozova, A. (2015) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2015.01051 · Cited by 16

Authors: Philo, J.
Affiliations: Alliance Protein Laboratories (United States) (US)
Corresponding author: Philo, John
ORCID: Philo, John
Venue: Current Pharmaceutical Biotechnology
Publisher: Bentham Science Publishers Ltd.
Published: 2009-06-01
Volume: 10
Issue: 4
Pages: 359-372
ISSN: 1389-2010 (ISSN-L)
DOI: 10.2174/138920109788488815
OpenAlex: W2007228224
Cited by: 196
References: 1
Citations by year: 2025: 4 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 7 · 2020: 8 · 2019: 14 · 2018: 12 · 2017: 11 · 2016: 13 · 2015: 22 · 2014: 19 · 2013: 13 · 2012: 24
FWCI: 6.97
Type: journal article
Language: en
Open access: closed
Locations: Current Pharmaceutical Biotechnology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
Keywords: protein aggregates, size exclusion chromatography, analytical ultracentrifugation, light scattering, pharmaceutical proteins, regulatory compliance, biophysical characterization
MeSH terms: Biopharmaceutics, Chromatography, Gel, Chemical Fractionation, Nephelometry and Turbidimetry, Particle Size, Proteins, Technology, Pharmaceutical, Ultracentrifugation, Multiprotein Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Critical Review of Methods for Size Characterization of Non-Particulate Protein Aggregates

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks